File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: An update in management of noncutaneous T-cell lymphomas

TitleAn update in management of noncutaneous T-cell lymphomas
Authors
Liang, RHSHwang, YY
Issue Date2010
PublisherHindawi Publishing Corporation. The Journal's web site is located at http://www.hindawi.com/journals/ah/
Citation
Advances In Hematology, 2010, v. 2010 How to Cite?
DOI: http://dx.doi.org/10.1155/2010/424786
AbstractT-cell lymphoma is a heterogeneous group of diseases. Except for ALK positive anaplastic large cell lymphoma, T-cell lymphoma responds to conventional chemotherapy unfavourably, and most patients carry poor prognosis. In recent years, efforts have been made to improve the outcome of T-cell lymphoma patients. Novel agents, high-dose therapy, and allogeneic stem cell transplantation are studied, and various results are reported in literature. This paper looks into the prognostication and treatment approach of different entities of noncutaneous T-cell lymphoma and would focus on the latest updates in its management. Copyright © 2010 Y. Y. Hwang and R. H. S. Liang.
Persistent Identifierhttp://hdl.handle.net/10722/163358
ISSN
1687-9104
2023 SCImago Journal Rankings: 0.553
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorLiang, RHSen_US
dc.contributor.authorHwang, YYen_US
dc.date.accessioned2012-09-05T05:30:29Z-
dc.date.available2012-09-05T05:30:29Z-
dc.date.issued2010en_US
dc.identifier.citationAdvances In Hematology, 2010, v. 2010en_US
dc.identifier.issn1687-9104en_US
dc.identifier.urihttp://hdl.handle.net/10722/163358-
dc.description.abstractT-cell lymphoma is a heterogeneous group of diseases. Except for ALK positive anaplastic large cell lymphoma, T-cell lymphoma responds to conventional chemotherapy unfavourably, and most patients carry poor prognosis. In recent years, efforts have been made to improve the outcome of T-cell lymphoma patients. Novel agents, high-dose therapy, and allogeneic stem cell transplantation are studied, and various results are reported in literature. This paper looks into the prognostication and treatment approach of different entities of noncutaneous T-cell lymphoma and would focus on the latest updates in its management. Copyright © 2010 Y. Y. Hwang and R. H. S. Liang.en_US
dc.languageengen_US
dc.publisherHindawi Publishing Corporation. The Journal's web site is located at http://www.hindawi.com/journals/ah/en_US
dc.relation.ispartofAdvances in Hematologyen_US
dc.titleAn update in management of noncutaneous T-cell lymphomasen_US
dc.typeArticleen_US
dc.identifier.emailLiang, RHS:rliang@hku.hken_US
dc.identifier.authorityLiang, RHS=rp00345en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1155/2010/424786en_US
dc.identifier.scopuseid_2-s2.0-79251538045en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-79251538045&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume2010en_US
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridLiang, RHS=26643224900en_US
dc.identifier.scopusauthoridHwang, YY=18134023400en_US
dc.identifier.issnl1687-9104-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats